COVID-19: Covaxin’s paediatric trials may begin in June, Bharat Biotech expects WHO approval by end of Q3 or Q4

Hyderabad: Bharat Biotech is all set to begin paediatric trials of its Covid-19 vaccine Covaxin from June. The company`s Business Development and International Advocacy Head Dr Raches Ella said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter, said an ANI report.

About WHO approval, Dr Raches said that the company has initiated the process and may get its approval soon, adding “A few of our products in the past got their approval. We expect approval for Covaxin by the end of Q3 (quarter) or Q 4.”

Holding a virtual conversation with members of FICCI Ladies Organisation (FLO) Hyderabad on “All About Vaccines”, Dr Raches Ella is quoted by ANI as saying, “I am happy that our hard work is paying off well as the vaccine is working well and saving lives.

Add Post

  • Separate tags with commas.
  • Select a category for your post
  • Write the full description of your Post
  •  

411 Comments

Leave A Comment

Your email address will not be published.